Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement has been reported in the published literature.
No clinical trials have been registered for high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement.
200 publications have been identified in PubMed for high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement. Research spans Basic Science / Preclinical (32%), Review / Meta-Analysis (22%), and Case Report / Case Series (10%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 58 | 32% |
Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 4:54 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
39 |
22% |
Patient case studies | 18 | 10% |
New treatment approaches | 18 | 10% |
Testing and diagnosis research | 17 | 9% |
Disease patterns and progression | 17 | 9% |
Clinical study results | 13 | 7% |
Raslan MA (2026). [PMID: 41895184](https://pubmed.ncbi.nlm.nih.gov/41895184/). *J Chromatogr B Analyt Technol Biomed Life Sci*. [Basic Science / Preclinical]
de Queiroz GN (2026). [PMID: 41043531](https://pubmed.ncbi.nlm.nih.gov/41043531/). *Biochim Biophys Acta Mol Basis Dis*. [Basic Science / Preclinical]
Alduaij W (2026). [PMID: 41071951](https://pubmed.ncbi.nlm.nih.gov/41071951/). *Blood advances*. [Clinical Trial Publication]
Brambillasca S (2026). [PMID: 41668618](https://pubmed.ncbi.nlm.nih.gov/41668618/). *Hematological oncology*. [Basic Science / Preclinical]
Donati G (2026). [PMID: 41255023](https://pubmed.ncbi.nlm.nih.gov/41255023/). *Br J Haematol*. [Diagnostic / Biomarker]
McCrury M (2026). [PMID: 41830329](https://pubmed.ncbi.nlm.nih.gov/41830329/). *Nucleic Acids Res*. [Basic Science / Preclinical]
Wang WJ (2026). [PMID: 41062339](https://pubmed.ncbi.nlm.nih.gov/41062339/). *Pathology*. [Case Report / Case Series]
Filip D (2026). [PMID: 41714403](https://pubmed.ncbi.nlm.nih.gov/41714403/). *Leukemia*. [Basic Science / Preclinical]
Perret RE (2026). [PMID: 41093144](https://pubmed.ncbi.nlm.nih.gov/41093144/). *Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc*. [Review / Meta-Analysis]
Anagnostopoulos I (2026). [PMID: 41749833](https://pubmed.ncbi.nlm.nih.gov/41749833/). *Cancers (Basel)*. [Review / Meta-Analysis]